These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1425832)

  • 1. Bladder wash cytology and flow cytometry for the diagnosis of transitional cell carcinoma of the urinary bladder.
    Romero J; Alos L; Mallofre C; Sole M; Gutierrez R; Alcover J; Carretero P
    Eur Urol; 1992; 21 Suppl 1():13-5. PubMed ID: 1425832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder wash flow cytometry in transitional cell carcinoma: useful or misleading?
    Solé M; Alós L; Mallofré C; Romero JA; Muntané J; Cardesa A
    Urol Res; 1995; 22(6):361-5. PubMed ID: 7740655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
    Kumar NU; Dey P; Mondal AK; Singh SK; Vohra H
    Diagn Cytopathol; 2001 Mar; 24(3):153-6. PubMed ID: 11241896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impulse cytophotometry and irrigation cytology in the diagnosis of bladder cancer].
    Maier G; Blech M; Droese M; Ringert RH
    Urologe A; 1990 Nov; 29(6):330-3. PubMed ID: 2291258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
    Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
    J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
    Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
    Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study.
    Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K; Bacus JW
    Diagn Cytopathol; 1995 Oct; 13(3):214-23; discussion 224. PubMed ID: 8575280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma.
    Badalament RA; Hermansen DK; Kimmel M; Gay H; Herr HW; Fair WR; Whitmore WF; Melamed MR
    Cancer; 1987 Oct; 60(7):1423-7. PubMed ID: 3304614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A useful monoclonal antibody (BL2-10D1) to identify tumor cells in urine cytology.
    Longin A; Fontaniere B; Berger-Dutrieux N; Devonec M; Laurent JC
    Cancer; 1990 Mar; 65(6):1412-7. PubMed ID: 2407335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.
    van Rhijn BW; van der Poel HG; Boon ME; Debruyne FM; Schalken JA; Witjes JA
    Urology; 2000 Mar; 55(3):363-7. PubMed ID: 10699611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of exfoliative urine cytology in combination with flexible cystoscopy in the diagnosis of recurrent transitional cell carcinoma of the urinary bladder.
    Loh CS; Spedding AV; Ashworth MT; Kenyon WE; Desmond AD
    Br J Urol; 1996 May; 77(5):655-8. PubMed ID: 8689105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry based on heterogeneity index score compared with urine cytology to evaluate their diagnostic efficacy in bladder tumor.
    Jitsukawa S; Tachibana M; Nakazono M; Tazaki H; Addonizio JC
    Urology; 1987 Feb; 29(2):218-22. PubMed ID: 3811103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
    Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients.
    Mora LB; Nicosia SV; Pow-Sang JM; Ku NK; Diaz JI; Lockhart J; Einstein A
    J Urol; 1996 Jul; 156(1):49-54; discussion 54-5. PubMed ID: 8648836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder.
    Melissourgos ND; Kastrinakis NG; Skolarikos A; Pappa M; Vassilakis G; Gorgoulis VG; Salla C
    Urology; 2005 Sep; 66(3):536-41. PubMed ID: 16140073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder.
    Gibanel R; Ribal MJ; Filella X; Ballesta AM; Molina R; Alcaraz A; Alcover JB
    Anticancer Res; 2002; 22(2B):1157-60. PubMed ID: 12168917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.